Stempoint Capital’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2M | Buy |
2,372,634
+774,040
| +48% | +$7.25M | 7.13% | 1 |
|
|
2025
Q1 | $19.6M | Sell |
1,598,594
-1,274,007
| -44% | -$15.7M | 6.26% | 2 |
|
|
2024
Q4 | $38M | Buy |
2,872,601
+1,141,410
| +66% | +$15.1M | 9.48% | 1 |
|
|
2024
Q3 | $33.3M | Buy |
1,731,191
+319,015
| +23% | +$6.14M | 9.98% | 1 |
|
|
2024
Q2 | $29M | Buy |
1,412,176
+311,188
| +28% | +$6.39M | 8.52% | 1 |
|
|
2024
Q1 | $26.2M | Buy |
1,100,988
+6,494
| +0.6% | +$155K | 6.93% | 3 |
|
|
2023
Q4 | $23.7M | Buy |
+1,094,494
| New | +$23.7M | 6.31% | 2 |
|